Glucuronides

"Glucuronides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Glycosides of GLUCURONIC ACID formed by the reaction of URIDINE DIPHOSPHATE GLUCURONIC ACID with certain endogenous and exogenous substances. Their formation is important for the detoxification of drugs, steroid excretion and BILIRUBIN metabolism to a more water-soluble compound that can be eliminated in the URINE and BILE.

Descriptor ID	D020719
MeSH Number(s)	D02.241.081.844.915.162.500 D02.241.152.811.162.750 D02.241.511.902.915.162.750 D09.811.922.162.750
Concept/Terms	Glucuronides Glucuronides

Below are MeSH descriptors whose meaning is more general than "Glucuronides".

Chemicals and Drugs [D]
Organic Chemicals [D02]
Carboxylic Acids [D02.241]
Acids, Acyclic [D02.241.081]
Sugar Acids [D02.241.081.844]
Uronic Acids [D02.241.081.844.915]
Glucuronates [D02.241.081.844.915.162]
Glucuronides [D02.241.081.844.915.162.500]
Acids, Aldehydic [D02.241.152]
Uronic Acids [D02.241.152.811]
Glucuronates [D02.241.152.811.162]
Glucuronides [D02.241.152.811.162.750]
Hydroxy Acids [D02.241.511]
Sugar Acids [D02.241.511.902]
Uronic Acids [D02.241.511.902.915]
Glucuronates [D02.241.511.902.915.162]
Glucuronides [D02.241.511.902.915.162.750]
Carbohydrates [D09]
Sugar Acids [D09.811]
Uronic Acids [D09.811.922]
Glucuronates [D09.811.922.162]
Glucuronides [D09.811.922.162.750]

Below are MeSH descriptors whose meaning is related to "Glucuronides".

Below are MeSH descriptors whose meaning is more specific than "Glucuronides".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Glucuronides" by people in this website by year, and whether "Glucuronides" was a major or minor topic of these publications.

Bar chart showing 11 publications over 7 distinct years, with a maximum of 4 publications in 2009

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1998	0	2	2
1999	0	1	1
2007	0	1	1
2009	2	2	4
2014	0	1	1
2016	1	0	1
2021	1	0	1

Below are the most recent publications written about "Glucuronides" by people in Profiles.

Foppe KS, Kujawinski EB, Duvallet C, Endo N, Erickson TB, Chai PR, Matus M. Analysis of 39 drugs and metabolites, including 8 glucuronide conjugates, in an upstream wastewater network via HPLC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2021 Jun 30; 1176:122747.

View in: PubMed
Parkinson OT, Teitelbaum AM, Whittington D, Kelly EJ, Rettie AE. Species Differences in Microsomal Oxidation and Glucuronidation of 4-Ipomeanol: Relationship to Target Organ Toxicity. Drug Metab Dispos. 2016 10; 44(10):1598-602.

View in: PubMed
Jang S, Sun J, Chen P, Lakshman S, Molokin A, Harnly JM, Vinyard BT, Urban JF, Davis CD, Solano-Aguilar G. Flavanol-Enriched Cocoa Powder Alters the Intestinal Microbiota, Tissue and Fluid Metabolite Profiles, and Intestinal Gene Expression in Pigs. J Nutr. 2016 04; 146(4):673-80.

View in: PubMed
Mamidi RN, Cuyckens F, Chen J, Scheers E, Kalamaridis D, Lin R, Silva J, Sha S, Evans DC, Kelley MF, Devineni D, Johnson MD, Lim HK. Metabolism and excretion of canagliflozin in mice, rats, dogs, and humans. Drug Metab Dispos. 2014 May; 42(5):903-16.

View in: PubMed
de Winter BC, van Gelder T, Sombogaard F, Shaw LM, van Hest RM, Mathot RA. Pharmacokinetic role of protein binding of mycophenolic acid and its glucuronide metabolite in renal transplant recipients. J Pharmacokinet Pharmacodyn. 2009 Dec; 36(6):541-64.

View in: PubMed
Joy MS, Hilliard T, Hu Y, Hogan SL, Wang J, Falk RJ, Smith PC. Influence of clinical and demographic variables on mycophenolic acid pharmacokinetics in antineutrophil cytoplasmic antibody-associated vasculitis. Ann Pharmacother. 2009 Jun; 43(6):1020-7.

View in: PubMed
van Hest RM, van Gelder T, Vulto AG, Shaw LM, Mathot RA. Pharmacokinetic modelling of the plasma protein binding of mycophenolic acid in renal transplant recipients. Clin Pharmacokinet. 2009; 48(7):463-76.

View in: PubMed
Joy MS, Hilliard T, Hu Y, Hogan SL, Dooley MA, Falk RJ, Smith PC. Pharmacokinetics of mycophenolic acid in patients with lupus nephritis. Pharmacotherapy. 2009 Jan; 29(1):7-16.

View in: PubMed
Jain A, Venkataramanan R, Sharma R, Kwong T, Abt P, Orloff M, Kashyap R, Tsoulfas G, Bozorgzadeh A. Pharmacokinetics of mycophenolic acid in live donor liver transplant patients vs deceased donor liver transplant patients. J Clin Pharmacol. 2008 May; 48(5):547-52.

View in: PubMed
Gold EB, Lasley B, Crawford SL, McConnell D, Joffe H, Greendale GA. Relation of daily urinary hormone patterns to vasomotor symptoms in a racially/ethnically diverse sample of midlife women: study of women's health across the nation. Reprod Sci. 2007 Dec; 14(8):786-97.

View in: PubMed

People

Explore

Similar Concepts

Top Journals